Our results differ from those reported by Kranendonk et al. who found that the levels of CD14 contained in extracellular vesicles were associated with a reduction in T2D development relative risk (Kranendonk et al., 2014). This evidence concerns the gene CD14 and type 2 diabetes mellitus.